Cargando…
Tumour scanning with indium-111 dihaematoporphyrin ether.
Photofrin II (dihaematoporphyrin ether/ester, DHE) was labelled with indium-111 and its biodistribution in tumour bearing mice compared with that of 111In chloride. The uptake and clearance of 111In labelled DHE differed markedly from that of indium-111 chloride in that the former was not taken up b...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971587/ https://www.ncbi.nlm.nih.gov/pubmed/2147858 |
_version_ | 1782134942693588992 |
---|---|
author | Quastel, M. R. Richter, A. M. Levy, J. G. |
author_facet | Quastel, M. R. Richter, A. M. Levy, J. G. |
author_sort | Quastel, M. R. |
collection | PubMed |
description | Photofrin II (dihaematoporphyrin ether/ester, DHE) was labelled with indium-111 and its biodistribution in tumour bearing mice compared with that of 111In chloride. The uptake and clearance of 111In labelled DHE differed markedly from that of indium-111 chloride in that the former was not taken up by the tissues as much as the latter. Scintillation scanning with a gamma-camera showed marked uptake of both 111In agents at the site of the tumour, but a much lower tissue background (excluding the abdominal organs) for the mice given 111In DHE. Tumour:muscle ratios of dissected tissues were 2-3 times higher in 111In DHE treated animals as compared to the uptake of 111In chloride. There was a distinct difference in the pattern of distribution of the two 111In preparations in the tissues. The major accumulation of 111In chloride was in the kidneys, whereas the highest uptake of 111In DHE was in the liver, the organ in which unlabelled porphyrins accumulate. Extraction and testing of materials from tumours of 111In DHE treated animals indicated that most of the tumour extractable 111In had remained associated with the porphyrin in vivo up to 4 days after injection. IMAGES: |
format | Text |
id | pubmed-1971587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1990 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-19715872009-09-10 Tumour scanning with indium-111 dihaematoporphyrin ether. Quastel, M. R. Richter, A. M. Levy, J. G. Br J Cancer Research Article Photofrin II (dihaematoporphyrin ether/ester, DHE) was labelled with indium-111 and its biodistribution in tumour bearing mice compared with that of 111In chloride. The uptake and clearance of 111In labelled DHE differed markedly from that of indium-111 chloride in that the former was not taken up by the tissues as much as the latter. Scintillation scanning with a gamma-camera showed marked uptake of both 111In agents at the site of the tumour, but a much lower tissue background (excluding the abdominal organs) for the mice given 111In DHE. Tumour:muscle ratios of dissected tissues were 2-3 times higher in 111In DHE treated animals as compared to the uptake of 111In chloride. There was a distinct difference in the pattern of distribution of the two 111In preparations in the tissues. The major accumulation of 111In chloride was in the kidneys, whereas the highest uptake of 111In DHE was in the liver, the organ in which unlabelled porphyrins accumulate. Extraction and testing of materials from tumours of 111In DHE treated animals indicated that most of the tumour extractable 111In had remained associated with the porphyrin in vivo up to 4 days after injection. IMAGES: Nature Publishing Group 1990-12 /pmc/articles/PMC1971587/ /pubmed/2147858 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Quastel, M. R. Richter, A. M. Levy, J. G. Tumour scanning with indium-111 dihaematoporphyrin ether. |
title | Tumour scanning with indium-111 dihaematoporphyrin ether. |
title_full | Tumour scanning with indium-111 dihaematoporphyrin ether. |
title_fullStr | Tumour scanning with indium-111 dihaematoporphyrin ether. |
title_full_unstemmed | Tumour scanning with indium-111 dihaematoporphyrin ether. |
title_short | Tumour scanning with indium-111 dihaematoporphyrin ether. |
title_sort | tumour scanning with indium-111 dihaematoporphyrin ether. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971587/ https://www.ncbi.nlm.nih.gov/pubmed/2147858 |
work_keys_str_mv | AT quastelmr tumourscanningwithindium111dihaematoporphyrinether AT richteram tumourscanningwithindium111dihaematoporphyrinether AT levyjg tumourscanningwithindium111dihaematoporphyrinether |